Bio Impact Capital LLC Repare Therapeutics Inc. Transaction History
Bio Impact Capital LLC
- $540 Million
- Q1 2025
A detailed history of Bio Impact Capital LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 819,924 shares of RPTX stock, worth $1.14 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
819,924
Previous 1,231,154
33.4%
Holding current value
$1.14 Million
Previous $1.61 Million
49.69%
% of portfolio
0.15%
Previous 0.24%
Shares
6 transactions
Others Institutions Holding RPTX
# of Institutions
54Shares Held
32.5MCall Options Held
50KPut Options Held
900-
Bvf Inc San Francisco, CA10.3MShares$14.4 Million0.45% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.79 Million1.76% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.62 Million0.1% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.12 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.68 Million5.46% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $58.3M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...